The funds will be used to bolster the company’s artificial intelligence (AI) infrastructure and support its expansion into Ghana and Kenya.

The funding round attracted diverse investors, including Launch Africa, Microtraction, Kaleo Ventures, Octerra Capital, Marula Square, XA Africa, ARM Labs, and Techstars.  

Founded in 2015 by Ayodeji Alaran, PBR initially operated in healthcare services but pivoted to big data and analytics in 2021.

The company provides pharmaceutical giants like Sanofi with critical market insights, enabling them to make data-driven decisions on product pricing, demand forecasting, and new product development tailored to African markets.

Pharmaceutical companies in Africa often face challenges related to overproduction, stemming from a limited understanding of market demand.

PBR addresses this issue by aggregating anonymized data—including drug quantities, prices, and purchase frequencies—from pharmacies.

This data helps companies align production volumes with actual market needs, reducing waste and improving efficiency.

The company’s AI-powered analytics dashboards deliver actionable insights, such as market share and consumption trends, across Nigeria and Ghana. 

Additionally, PBR offers a generative AI feature that allows users to generate custom analytics by asking specific questions. Its clientele includes pharmaceutical companies, consulting firms, NGOs, and multilateral organizations.

“Being backed by some of the most reputable venture capital investors and angels in Africa inspires us to do more and validates the need to close the gap in healthcare big data,” said Alaran. “This data will power AI and innovation while unlocking global life sciences growth driven by Africa.”

PBR Life Sciences was part of the second cohort of the ARM Labs Lagos Techstars Accelerator program.